Quick answer: BPC-157, TB-500, and KPV are three of the most-studied peptides in tissue-repair research, each through a different pathway. BPC-157 is researched for VEGFR2-driven angiogenesis and tendon/gut repair, TB-500 for actin regulation and systemic cell migration, and KPV for anti-inflammatory signaling. Sold for research use only.
What each is studied for
BPC-157 is a stable gastric pentadecapeptide researched mainly for angiogenesis (new blood-vessel formation) via VEGFR2, alongside FAK-paxillin, Egr-1, and Akt/PI3K signaling. A distinguishing feature in the literature is its studied role in tendon, ligament, bone, and gastrointestinal repair.
TB-500 is a synthetic fragment of thymosin β4, an actin-binding protein. Its research is built on actin regulation driving cell migration and tissue regeneration across tissue types, with additional anti-inflammatory, cardioprotective, and neuroprotective research interest. (For a deeper head-to-head, see our BPC-157 vs TB-500 comparison.)
KPV is a tripeptide fragment of α-MSH (alpha-melanocyte-stimulating hormone) studied primarily for anti-inflammatory signaling — it is researched for downregulating pro-inflammatory pathways (NF-κB) and is a common tool in gut-inflammation and skin-repair research. It complements the structural-repair focus of BPC-157 and TB-500.
Why they’re studied together
The three map to complementary axes of recovery research: angiogenesis + structural repair (BPC-157), cell migration + systemic regeneration (TB-500), and inflammation modulation (KPV). This is why combination and blend research designs frequently reference them together.
What the research literature covers
- VEGFR2 angiogenesis and tendon/ligament/bone repair (BPC-157)
- Actin regulation, cell migration, and wound healing (TB-500)
- NF-κB and pro-inflammatory pathway downregulation (KPV)
- Gastrointestinal-tract repair and gut-barrier research (BPC-157, KPV)
- Anti-inflammatory, cardioprotective, and neuroprotective models
Frequently asked questions
What are the main recovery research peptides?
BPC-157 (angiogenesis/structural repair), TB-500 (cell migration/regeneration), and KPV (anti-inflammatory) are among the most-studied.
What is the difference between BPC-157 and TB-500?
BPC-157 is studied more for localized structural repair via VEGFR2 angiogenesis; TB-500 for systemic cell migration via actin regulation. See our full comparison page.
What is KPV studied for?
Anti-inflammatory signaling — it is researched for downregulating NF-κB-driven inflammation, with interest in gut and skin research.
Can these be researched together?
Yes — their complementary mechanisms (repair, regeneration, inflammation) are why combination research designs and blends exist.
Are these for human use?
No. Portal to Wellness sells these strictly for laboratory and research use only. Nothing here is medical advice.
Primary-literature anchors
Cite primary sources: Sikiric et al. (BPC-157 angiogenesis/tendon/gut research); Goldstein et al. (thymosin β4/actin wound-healing research); KPV/α-MSH anti-inflammatory research (e.g., Dalmasso/Sitaraman gut-inflammation studies). Link via PubMed.
For research use only. Not for human or veterinary use, diagnosis, treatment, or prevention of any condition. Not evaluated by the FDA. Author: Charles Fowler. Last updated: May 2026.